Clinical Trials Directory

Trials / Sponsors / Processa Pharmaceuticals

Processa Pharmaceuticals

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Breast Cancer, TNBC - Triple-Negative Breast Cancer, HER2-negative Breast Cancer
Phase 22024-10-02
CompletedSafety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
Gastroparesis
Phase 22022-03-09
CompletedA Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory G
Advanced Cancer, Refractory Cancer, Tumor Gastric
Phase 12021-06-18
TerminatedA Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
Necrobiosis Lipoidica
Phase 22021-04-12
CompletedA Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica
Necrobiosis Lipoidica
Phase 22018-11-07
CompletedStudy to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared
Healthy
Phase 12018-02-26
CompletedRX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Phase 1 / Phase 22017-10-02
CompletedDose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
Solid Tumor, Metastatic Bladder Cancer
Phase 1 / Phase 22013-12-01
TerminatedOpen Label Extension Study of HT-100 in Patients With DMD
Duchenne Muscular Dystrophy
Phase 22013-10-01
TerminatedSafety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrop
Duchenne Muscular Dystrophy
Phase 1 / Phase 22013-05-01